Salmon calcitonin appears ineffective in the management of knee OA treatment in 2 RCTs .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
Osteoarthritis Cartilage. 2015 Apr;23(4):532-43.Two randomized control trials, with a combined 2206 patients, studied the effects of salmon calcitonin (sCT) in patients with symptomatic knee osteoarthritis. Changes in joint space width, pain, function, and safety were evaluated over a 24 month period after treatment began. The results of these trials indicated that salmon calcitonin did not have an effect on joint space width in comparison to placebo and that this treatment was unable to provide reproducible benefits for patient pain and function. The use of salmon calcitonin also resulted in an increased incidence of mild to moderate adverse events.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
